NEURONES: Declaration Of Transactions On Treasury Shares (May 25 To 29, 2026)

2026-06-01 07:16:39

(MENAFN- GlobeNewsWire - Nasdaq) Nanterre, June 1, 2026

Declaration of transactions on treasury shares
(period from May 25 to 29, 2026)

As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between May 25 and 29, 2026 (ISIN code FR0004050250):

Day	Total daily volume (in number of shares)	Weighted average price (unit daily)
05/25/2026	-	-
05/26/2026	3,331	€38.14
05/27/2026	12,925	€38.04
05/28/2026	-	-
05/29/2026	-	-
Total	16,256

As of May 29, 2026, excluding the liquidity contract, NEURONES now holds 462,002 of the 24,328,716 shares comprising the company's capital (i.e., 1.90%).

All press releases relating to the share buyback program are published in the "Regulated Information" section (under "Weekly declarations of the share buyback transactions" and "Share buyback programs") of the company's website.

About NEURONES

With 7,400 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations with their digital projects, IT infrastructures transformation and AI adoption.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03
...

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
...

Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
...

Attachment

neurones-weekly-declaration-transactions-treasury-shares-may-25-to-29-2026

MENAFN01062026004107003653ID1111192720

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.